Category Archives: November 2011

Plugging in to London’s Capital Markets and Support

The UK is at the forefront of life sciences innovation. Break through companies across the UK are creating cutting edge therapies, highly skilled jobs, and driving economic growth. But business and Government recognise that more still needs to be done … Continue reading

Posted in November 2011 | Leave a comment

Making Life Sciences Fashionable – What Can We Learn?

Recently, I was fortunate to be invited to the Kruger Cowne Breakfast Club event held in London to hear two of their clients – Caroline Rush (CEO, British Fashion Council) and Millie Mackintosh (Entrepreneur, Designer, Model and Fitness & Health … Continue reading

Posted in November 2011 | Leave a comment

Artificial Intelligence and life sciences-the great coming?

The Prism Series “pop up event” Cancer research UK December 2017 Christmas comes but once a year. To most of us this is a really good thing as it costs so much. We look forward to all the festivities, parties … Continue reading

Posted in November 2011 | Leave a comment

My Letter to you Dear Entrepreneur…..

Putting the c in Science – Commercialization, Community and Capital by Sharon Vosmek I am very much looking forward to my up and coming talk at the 2017 ON Helix conference. As an early stage investor, I especially enjoy opportunities … Continue reading

Posted in November 2011 | Leave a comment

One Nucleus Input to the Industrial Strategy

OPEN LETTER Dear One Nucleus members and esteemed readers As many of you will know, the British Government launched a Green Paper for wide consultation regarding its future Industrial Strategy. One Nucleus is delighted that at least 3 of the … Continue reading

Posted in November 2011 | Leave a comment

Unlocking the Power of Genomics

The speed of Next Generation Sequencing now enables us to read every letter of every gene from DNA samples of patients in medical research. This is a significant advance on previous technology, which could only detect common differences between people … Continue reading

Posted in December 2016, November 2011 | Tagged , , , , , , | Leave a comment

Genesis 2015: A Bioscientist’s View

Since the turn of the millennium, the Genesis conference has become one of the highlights of the UK biotech and pharmaceutical industry calendar. It is held in central London every December, always coveres the full range of these industries, covering … Continue reading

Posted in January 2016, November 2011 | Tagged , , , , , , | Leave a comment

Funding an innovative science base

Given our life sciences University base, the UK should have a biotech ecosystem equivalent to the Boston or Bay areas. We don’t today. There are many reasons for this including the lack of an entrepreneurial culture, management talent, knowledge transfer … Continue reading

Posted in November 2011 | Leave a comment

The Era of Biosimilars

  A decade ago the focus of the biotech world was on biologicals. The names Humira®, Enbrel®, Lucentis®, Remicade® etc. were common place with analysts accurately predicting billion dollar global sales of these products. In the last five years, while … Continue reading

Posted in November 2011 | Leave a comment

The Shrinking Black Box – Mehryar Behizad, Pirus Consulting

Over the past thirty years several trends have emerged in the healthcare industry, relating on the one hand, to the advancing technology and the shape of the innovating organisations and on the other, the related Regulatory and Quality Management landscape … Continue reading

Posted in November 2011 | Tagged , , , , , , , , , , , , | Leave a comment